Skip to main content
SpringerLink
Log in

Polypharmazie in der Gerontopsychiatrie

  • Chapter
Polypharmazie in der Behandlung psychischer Erkrankungen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

9. Literatur

  1. Allen TB, McEvoy JP (2002) Galantamine for treatment-resistant schizophrenia. Am J Psychiatry 159: 1244–1245

    Article  PubMed  Google Scholar 

  2. Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E (2004) A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry 65: 114–119

    PubMed  Google Scholar 

  3. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, Petersen LA, Small SD, Sweitzer BJ, Vander Vliet M et al (1999) Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Int Med 159: 2553–2560

    Article  CAS  Google Scholar 

  4. Bergman J, Brettholz I, Shneidman M, Lerner V (2003) Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer’s type. Clin Neuropharmacol 26: 88–92

    Article  PubMed  CAS  Google Scholar 

  5. Brazeau SM (2001) Polypharmacy and the elderly. Canadian J CME

    Google Scholar 

  6. Bruno JJ, Ellis JJ (2005) Herbal Use Among US Elderly: 2002 National Health Interview Survey (April). Ann Pharmacother

    Google Scholar 

  7. Buysse DJ, Reynolds CF, III, Houck PR, Perel JM, Frank E, Begley AE, Mazumdar S, Kupfer DJ (1997) Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy? J Clin Psychiatry 58: 426–432

    PubMed  CAS  Google Scholar 

  8. Carlson JE (1996) Perils of polypharmacy: 10 steps to prudent prescribing. Geriatrics 51: 26–30, 35

    PubMed  CAS  Google Scholar 

  9. Carnahan RM, Lund BC, Perry PJ, Chrischilles EA (2004) The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatrics Soc 52: 2082–2087

    Article  Google Scholar 

  10. Chutka DS, Evans JM, Fleming KC, Mikkelson KG (1995) Symposium on geriatrics-part I: drug prescribing for elderly patients. Mayo Clin Proceed 70: 685–693

    Article  CAS  Google Scholar 

  11. Curtis LH, Ostbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al Khatib SM, Usdin Yasuda S, Dans PE, Wright A, Califf RM (2003) Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med 114: 135–141

    Article  PubMed  CAS  Google Scholar 

  12. Drimer T, Shahal B, Barak Y (2004) Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol 19: 27–29

    Article  PubMed  CAS  Google Scholar 

  13. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Int Med 163: 2716–2724

    Article  Google Scholar 

  14. Finkel SI, Mintzer JE, Dysken M, Krishnan KRR, Burt T, McRae T (2004) A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer’s disease in outpatients treated with donepezil. Int J Geriatric Psychiatry 19: 9–18

    Article  Google Scholar 

  15. Flint AJ, Rifat SL (1996) The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 36: 95–105

    Article  PubMed  CAS  Google Scholar 

  16. Friedman JI, Adler DN, Howanitz E, Harvey PD, Brenner G, Temporini H, White L, Parrella M, Davis KL (2002) A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry 51: 349–357

    Article  PubMed  CAS  Google Scholar 

  17. Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J (2001) The appropriateness of drug use in an older nondemented and demented population. J Am Geriatrics Society 49: 277–283

    Article  CAS  Google Scholar 

  18. Graves T, Hanlon JT, Schmader KE, Landsman PB, Samsa GP, Pieper CF, Weinberger M (1997) Adverse events after discontinuing medications in elderly outpatients. Arch Int Medicine 157: 2205–2210

    Article  CAS  Google Scholar 

  19. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J (2005) The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 118: 251–258

    Article  PubMed  Google Scholar 

  20. Hamann J, Ruppert A, Auby P, Pugner K, Kissling W (2003) Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database. Int Clin Psychopharmacol 18: 237–242

    Article  PubMed  Google Scholar 

  21. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR (1996) A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 100: 428–437

    Article  PubMed  CAS  Google Scholar 

  22. Huang F, Lasseter KC, Janssens L, Verhaeghe T, Lau H, Zhao Q (2002) Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together. J Clin Pharmacol 42: 1341–1351

    Article  PubMed  CAS  Google Scholar 

  23. Hughes CM (2004) Medication non-adherence in the elderly: how big is the problem? Drugs & Aging 21: 793–811

    Article  Google Scholar 

  24. Ibach B, Hajak G (2005) Behandlung der Alzheimerdemenz unter Berücksichtigung der Polypharmacie. Neuropsychiatrische Zeitung 2: 12–13

    Google Scholar 

  25. Klatte ET, Scharre DW, Nagaraja HN, Davis RA, Beversdorf DQ (2003) Combination therapy of donepezil and vitamin E in Alzheimer disease. Alzheimer Disease And Associated Disorders 17: 113–116

    Article  PubMed  CAS  Google Scholar 

  26. Lavretsky H, Kim MD, Kumar A, Reynolds CF III (2003) Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry 64: 1410–1414

    PubMed  CAS  Google Scholar 

  27. Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR Jr (2004) Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutrition 80: 1194–1200

    CAS  Google Scholar 

  28. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL (2004) Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore. Ann Acad Med, Singapore 33: 220–227

    CAS  Google Scholar 

  29. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivela SL, Isoaho R (2002) Psychotropics among the home-dwelling elderly-increasing trends. Int J Geriatric Psychiatry 17: 874–883

    Article  CAS  Google Scholar 

  30. Miller ER, III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Internal Med 142: 37–46

    CAS  Google Scholar 

  31. Moore AR, O’Keeffe ST (1999) Drug-induced cognitive impairment in the elderly. Drugs & Aging 15: 15–28

    Article  CAS  Google Scholar 

  32. Moretti R, Torre P, Antonello RM, Cazzato G, Griggio S, Ukmar M, Bava A (2004) Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study. Int J Clin Practice 58: 346–353

    Article  CAS  Google Scholar 

  33. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39: 1159–1165

    PubMed  CAS  Google Scholar 

  34. Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, Begley AE, Mazumdar S, Reynolds CF (2001) A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 62: 597–604

    Article  PubMed  CAS  Google Scholar 

  35. Nolan L, O’Malley K (1988) Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatrics Society 36: 142–149

    CAS  Google Scholar 

  36. Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA (2004) Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson’s disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Brit J Clin Pharmacol 58: 41–49

    Article  CAS  Google Scholar 

  37. Prein RF, Klett CJ, Caffey EM (1976) Polypharmacy in the psychiatric treatment of elderly hospitalized patients: a survey of 12 Veterans Administration Hospitals. Dis Nerv Syst 37: 333–336

    PubMed  CAS  Google Scholar 

  38. Rektorova I, Rektor I, Bares M, Dostal V, Ehler E, Fanfrdlova Z, Fiedler J, Klajblova H, Kulist’ak P, Ressner P (2003) Pramipexole and pergolide in the treatment of depression in Parkinson’s disease: a national multicentre prospective randomized study. European Journal Of Neurology: The Official Journal Of The European Federation Of Neurological Societies 10: 399–406

    CAS  Google Scholar 

  39. Rosse RB, Deutsch SI (2002) Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia. Clin Neuropharmacol 25: 272–275

    Article  PubMed  Google Scholar 

  40. Schmucker DL, Vesell ES (1999) Are the elderly underrepresented in clinical drug trials? J Clin Pharmacol 39: 1103–1108

    PubMed  CAS  Google Scholar 

  41. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatric Psychiatry: Official Journal Of The American Association For Geriatric Psychiatry 5: 97–106

    CAS  Google Scholar 

  42. Siegmund W (2001) Arzneitherapie im Alter in Pharmakotherapie Klinische Pharmakologie. In: Lemmer B, Brune K (Hrsg) Urban & Fischer, München Jena

    Google Scholar 

  43. Stahl SM, Markowitz JS, Gutterman EM, Papadopoulos G (2003) Co-use of donepezil and hypnotics among Alzheimer’s disease patients living in the community. J Clin Psychiatry 64: 466–472

    Article  PubMed  CAS  Google Scholar 

  44. Stryjer R, Strous RD, Bar F, Werber E, Shaked G, Buhiri Y, Kotler M, Weizman A, Rabey JM (2003) Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia. Clin Neuropharmacol 26: 12–17

    Article  PubMed  CAS  Google Scholar 

  45. Stryjer R, Strous RD, Shaked G, Bar F, Feldman B, Kotler M, Polak L, Rosenzcwaig S, Weizman A (2003) Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol 18: 93–96

    Article  PubMed  Google Scholar 

  46. Suzuki T, Uchida H, Tanaka KF, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H (2004) Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. The International Journal of Neuropsychopharmacology/Official Scientific Journal Of The Collegium Internationale Neuropsychopharmacologicum (CINP) 7: 133–142

    CAS  Google Scholar 

  47. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine Study G: Memantine treatment in patients with moderate to severe Alzheimer’s disease already receiving donepezil: a randomized controlled trial. JAMA: The Journal Of The American Medical Association 291: 317–324

    Article  CAS  Google Scholar 

  48. Tollefson GD, Bosomworth JC, Heiligenstein JH, Potvin JH, Holman S (1995) A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. International Psychogeriatrics/IPA 7: 89–104

    Article  PubMed  CAS  Google Scholar 

  49. Turnheim K (2001) Pharmakotherapie im Alter in Allgemeine und spezielle Pharmakologie und Toxikologie. In: Forth W, Henschler D, Rummel W, Förstermann U, Starke K (Hrsg) Urban & Fischer, München Jena

    Google Scholar 

  50. Viola R, Csukonyi K, Doro P, Janka Z, Soos G (2004) Reasons for polypharmacy among psychiatric patients. Pharmacy World & Science: PWS 26: 143–147

    Article  Google Scholar 

  51. Weiser M, Rotmensch HH, Korczyn AD, Hartman R, Cicin-Sain A, Anand R (2002) Rivastigmine-Risperidone Study G: A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances. Int J Geriatric Psychiatry 17: 343–346

    Article  Google Scholar 

  52. Whyte EM, Basinski J, Farhi P, Dew MA, Begley A, Mulsant BH, Reynolds CF (2004) Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 65: 1634–1641

    Article  PubMed  CAS  Google Scholar 

  53. Wilkinson D, Holmes C, Woolford J, Stammers S, North J (2002) Prophylactic therapy with lithium in elderly patients with unipolar major depression. Int J Geriatric Psychiatry 17: 619–622

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bezirksklinikum Regensburg, Universitätsstrasse 84, 93053, Regensburg

    Dr. med. Bernd Ibach

Authors
  1. Dr. med. Bernd Ibach
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Ibach, B. (2006). Polypharmazie in der Gerontopsychiatrie. In: Polypharmazie in der Behandlung psychischer Erkrankungen. Springer, Vienna. https://doi.org/10.1007/3-211-31221-8_6

Download citation

  • DOI: https://doi.org/10.1007/3-211-31221-8_6

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-25286-4

  • Online ISBN: 978-3-211-31221-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation